MarketsandMarketsResearchfuture

  Stereotactic Surgery Devices Research Report: By Product Type (gamma Knife, Linear Accelerators, Proton Beam Therapy, Cyberknife), by Application (Brain Tumour, Arteriovenous Malformations, Parkinson disease, Epilepsy, Other)-Forecast till 2027\ GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/6791 Market Highlights: The global stereotactic surgery devices market held a market value of USD 16.59 billion in the year 2017 and is expected to grow at a CAGR of 5.2% during the forecast period. Stereotactic surgery is a minimally invasive form of surgical intervention that uses a 3D coordinate system to locate small targets inside the body and perform actions such as ablation and biopsy. The rising preference for minimally invasive surgeries, increasing adoption of stereo static surgery devices, and growing prevalence of brain-related diseases such as Parkinson’s disease, brain tumor, and others is anticipated to drive the growth of the market over the assessment

  Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2027 The controlled release drug delivery market was estimated USD 31.96 billion in 2017 and expected to reach USD 70.15 billion by 2023 at a CAGR of 14.0% during the forecast period. However, factors such as less awareness and higher cost per dosage may hinder the market growth during the forecast period. GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/6794 Segmentation The global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end user. By route of administration the market is segmented into oral, injectable, ocular, nasal, topical and implantable. The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal. On the basi

  Cannula Market Research Report: by Product (Cardiac, Nasal, Vascular, Dermatology, Arthroscopy, Other), by Material (Plastic, Silicone, Metal), by Application (Cardiovascular Surgery, Oxygen Therapy, General Surgery, Other), End User – Forecast Till 2027 The Global Cannula Market is anticipated to hold a market value of USD 113 million in the year 2017 and is expected to grow at a CAGR of 6.7% during the forecast period. Cannula is a thin tube entered into a vein or body cavity in order to administer medication or to drain off fluid or to insert some surgical instrument. GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/6937 Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the easy availability of advanced healthcare infrastructure and rising awareness about minimally invasive surgeries. According to a report published by the American Society of Plastic Surgeons, in the US, total cosmetic minimally-invasive p

  Oncology Information Systems Market Research Report: by Product & Service Type (Software, Professional Services), Application (Medical Oncology, Radiation Oncology, Surgical Oncology), End User (Hospitals & Oncology Clinics) – Forecast Till 2027 GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/7080 Market Highlights: The Global Oncology Information Systems (OIS) Market held a market value of USD 2,356.6 million in 2017 and is projected to grow at a CAGR of 7.5% over the forecast period . OIS is a complete information and image management solution that enables the management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries. Overall, this system allows healthcare professionals to oversee all aspects of oncology care for their patients. Factors accounted for the market growth are globally growing older population coupled with rising incidence of cancer, the presence of favorable government initiatives, mounti

  Advanced Wound Therapy Devices Market Research Report: by Type (Negative Pressure Wound Therapy Systems, Electric Stimulation Devices, Hyperbaric Oxygen Equipment, Pressure Relief Devices, Others), by End-user (Hospitals & Clinics, Home Care Settings, Others), and Region – Forecast till 2027 The global advanced wound therapy devices market is anticipated to touch a value of USD 2,804.53 million by 2023, asserts Market Research Future (MRFR). The market can showcase 6.70% CAGR from 2018 to 2023 (forecast period). GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/7421 Segmentation Analysis: The advanced wound therapy devices market is segmented by type and end-user. By type, negative pressure wound therapy systems accounted for 42.9% share in 2017, followed by pressure relief devices (28.2%), hyperbaric oxygen equipment (15.2%), electric stimulation devices (7.9%), and others (5.8%). Negative pressure wound therapy systems can attain revenue close to USD 1

  Surgical Snare Market Research Report: Information by Usability (Reusable and Single-Use) Application (Laparoscopy, Endoscopy, Cystoscopy, Otoscopy, Laryngoscopy, and Neuro-Endoscopy), End User (Hospitals and Clinics)- Forecast till 2027 The global surgical snare market is expected to grow at an approximate CAGR of 4.4% during the forecast period, 2018–2023. GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/7842 Segmentation The global surgical snare market is segmented on the basis of usability, application, end user, and region. On the basis of usability, the global surgical snare market is segmented into reusable and single-use. By application, the global surgical snare market by application is categorized into laparoscopy, endoscopy, cystoscopy, otoscopy, laryngoscopy, neuroendoscopy, and others. By end-user, the global surgical snare market is categorized into hospitals & clinics, ambulatory surgical centers, and others. Regional Analysis The Americ

  Molecular Diagnostics Market Research Report: Information By Product (Reagents & Kits, Instruments and Services & Software), Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray and others), Application (Infectious Diseases, Oncology, Genetic Tests and others), End User (Hospitals & Clinics, Diagnostic Laboratories and others) – Forecast till 2027 The Rising Prevalence of Infectious Diseases and Rising Number of Cases of Different Types of Cancer is Expected to Boost the Growth of the Global Molecular Diagnostics Market at a CAGR of 8.57% During the Forecast Period 2019 to 2025. :  GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/1171 Market Segmentation The molecular diagnostics market has been segmented into application, end user, product, and technique. Based on the segment which is application, the market is categorized on the basis of infectious diseases, oncology, genetic tests, and ot

  Active Pharmaceutical Ingredient For Cancer Market Report: Information by Type (Tyrosine Kinase Inhibitor (Tinib), Proteasome Inhibitors (Parib), BRAF Kinase Inhibitors (Rafenib), Phosphatidylinositol 3-Kinase Inhibitors (Lisib), SMO Receptor Antagonists (Degib), Cyclin Dependent Kinase Inhibitors (Ciclib) and others), Indications (Blood Cancer, Skin Cancer, Lung Cancer, Breast Cancer, Pancreas Cancer, Others), End User (Pharmaceutical Companies, Research Organizations, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2027 GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/8300 The Global Active Pharmaceutical Ingredient (API) for Cancer Market is expected to grow significantly over the forecast period. The API for cancer market held a valuation of USD 19,500.00 million in 2018 and is projected to register a CAGR of 8.1% over the forecast period. Segmentation The global API for cancer market is segmented based o

  Electronic Trial Master File (eTMF) Systems Market: By Component (Software, Services), Deployment Mode (Cloud/Web-Based, On-Premise), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others), Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast to 2027 GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/8772 According to MRFR analysis,  Global eTMF Systems Market  is expected to register a  CAGR of 13.11%  during the forecast period of  2019 to 2025  and anticipated to reach  USD 1,825 Million by 2025. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada. The eTMF systems market in the Americas has been segmented into North America and Latin America, with the North American ma

  Human Insulin Market: Information by Type (Traditional Human Insulin (Premixed Traditional, Intermediate Acting and Short-Acting), Modern Human Insulin (Premixed Modern, Long-Acting and Rapid Acting) and Brand (Lantus, Novorapid, Humalog, Novomix, Levemir, Apidar, Humulin and Insuman)) – Forecast till 2027 The human insulin market is estimated at  USD 90,812.40 Million till 2025  and is expected to grow at a CAGR of  12.10%  within forecasted period. GET FREE SAMPLE COPY @  https://www.marketresearchfuture.com/sample_request/951 company profile and country level customization on reports. This report includes a study of strategies, of major market players. It includes the product portfolios, developments of leading major players such as Biocon Ltd. (India), Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Adocia (France.), Merck & Co. (U.S.), Julphar (UAE), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline Plc (U.K.), Oramed Pharmaceuticals, Inc. (Israel), Novo Nordisk A/S (D